Renaissance Technologies’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $40K | Buy |
|
|||||
|
2023
Q4 | $42K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $24K | Buy |
|
|||||
|
2023
Q1 | $32K | Sell |
|
|||||
|
2022
Q4 | $54K | Sell |
|
|||||
|
2022
Q3 | $114K | Buy |
|
|||||
|
2022
Q2 | $251K | Buy |
|
|||||
|
2022
Q1 | $404K | Buy |
|
|||||
|
2021
Q4 | $344K | Sell |
|
|||||
|
2021
Q3 | $1.41M | Sell |
|
|||||
|
2021
Q2 | $2.04M | Buy |
|
|||||
|
2021
Q1 | $1.45M | Sell |
|
|||||
|
2020
Q4 | $2.95M | Sell |
|
|||||
|
2020
Q3 | $4.23M | Sell |
|
|||||
|
2020
Q2 | $7.87M | Buy |
|
|||||
|
2020
Q1 | $2.72M | Buy |
|
|||||
|
2019
Q4 | $2.54M | Buy |
|
|||||
|
2019
Q3 | $1.28M | Buy |
|
|||||
|
2019
Q2 | $729K | Buy |
|
|||||
|
2019
Q1 | $379K | Buy |
|
|||||
|
2018
Q4 | $171K | Buy |
|
|||||
|
2018
Q3 | $285K | Buy |
|
|||||
|
2018
Q2 | $257K | Buy |
|
|||||
|
2018
Q1 | $251K | Buy |
|
|||||
|
2017
Q4 | $1.95M | Buy |
|
|||||
|
2017
Q3 | $568K | Buy |
|
|||||
|
2017
Q2 | $373K | Buy |
|
|||||
|
2017
Q1 | $191K | Buy |
|
|||||
|
2016
Q4 | $101K | Buy |
|
|||||
|
2016
Q3 | $143K | Buy |
|
|||||
|
2016
Q2 | $60K | Buy |
|